Subject: FW: Veille scientifique 24 mars : coronavirus COVID-19
From: Dominique Lavallée (RRSSSN)<[email-masked]>
To: "Imane Cheriet (RRSSSN)" <[email-masked]>, "Civil Security Communication (DO NOT REPLY)" <[email-masked]>, "Maria Helena Del Castillo (CIUSSSCN)" <[email-masked]>
Date: Tue, 24 Mar 2020 16:46:59 +0000

Bonjour,

@ Maria Helena: SVP partager à l’équipe MI

@ Civil Security Communication : SVP partagez à la cellule sécurité civile régionale et aux 2 cellules sécurité régionales locales  - volet SANTÉ PUBLIQUE

Bonne journée,

From: Chantal Richard <[email-masked]>
Sent: Tuesday, March 24, 2020 12:42 PM
Subject: Veille scientifique 24 mars : coronavirus COVID-19

Destinataires :

Ministère de la Santé et des Services Sociaux

Membres du Comité de coordination de l’INSPQ

Membres du Comité sur les infections nosocomiales du Québec (CINQ)

Membres du Comité MRSI

Directions de santé publique

Équipe Immunisation et infections nosocomiales de l’INSPQ

Bonjour,

Il me fait plaisir de vous transmettre la veille scientifique sur le Coronavirus COVID-19. Celle-ci est triée, mise à jour quotidiennement et en constante évolution.

Des liens directs sont disponibles au bas de cette veille pour accéder aux publications triées selon des catégories spécifiques. De plus, vous pouvez visualiser tous les résultats précédents en cliquant sur la boîte « Plus de résultats ».

Il est à noter que pour une question de logistique, nous ne traiterons aucune demande d’ajout à la liste de diffusion de cette veille scientifique. Au besoin, il vous est toutefois possible de transférer cette veille.

Bonne journée et au plaisir,

Chantal Richard, inf. B.Sc.
Conseillère en soins infirmiers

Immunisation et infections nosocomiales

Direction des risques biologiques et santé au travail (DRBST)
[email-masked]<mailto:[email-masked]>

418-650-5115 poste 6352

INSPQ <https://can01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.inspq.qc.ca%2F&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652205958829&sdata=GXR8YbHGHHB2jXJlMKbh68xNbJQqeePVpeGdepiDdn8%3D&reserved=0> Centre d'expertise et de référence en santé publique
2400 rue d’Estimauville, Québec (Québec) G1E 7G9

<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3D07d38121f0%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652205958829&sdata=xFg0QJyFWAAw6um4ID579Xpaa0ffEqlenNuyQf8vexY%3D&reserved=0>

Veille scientifique : coronavirus COVID-19

Bulletin du 24/03/2020

Quantitative computed tomography analysis for stratifying the severity of Coronavirus Disease 2019<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3D4f9486494e%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652205968824&sdata=qF9ZKzrViQ%2BqQV%2BRW7H25f%2B7mq%2B%2Bia%2BWmmHh24VUZgo%3D&reserved=0>

  _____

Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3D218fbbf679%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652205968824&sdata=T1jJYOwbMk7lo%2BDEi%2Bwx6XswcZl2oTjR72MawnwPGQo%3D&reserved=0>

  _____

Systematic review of COVID-19 in children show milder cases and a better prognosis than adults.<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3D5d38e45fc9%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652205978819&sdata=tfK%2Bgp4IJeJuUKQF2jW6GaOp06wkuPC9yx0xhyhli%2BY%3D&reserved=0>

  _____

A COVID-19 Transmission within a family cluster by presymptomatic infectors in China.<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3D6e7ed572b0%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652205978819&sdata=2Q36VCxx6m8LasHn0gKMpeHrW%2BZKOexg3LVJfyEMtkw%3D&reserved=0>

  _____

Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach.<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3D4112c49959%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652205988812&sdata=rAtVuT8kgvwNhOG98KGYU0y2R7h3eWPla49gf2f70Co%3D&reserved=0>

  _____

A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence.<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3Dc2d9722048%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652205988812&sdata=bLysIngdcVwCsax%2BiLqOKUr7jZuNIi6h3%2Bi9SZBMLZc%3D&reserved=0>

  _____

Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic.<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3Dec63fad88f%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652205998807&sdata=jHYdBD5xbgpxPaoNTju8h9Y1I6Eh4kTx%2BCfw%2FchF5f8%3D&reserved=0>

  _____

Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection.<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3Df900ecb361%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652205998807&sdata=GFfMPUIs8do%2BKgczgdMjZIopdoFtTmxBSLinxREyOUY%3D&reserved=0>

  _____

COVID-19: mitigating transmission via wastewater plumbing systems<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3Dd937c7e04d%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652206008797&sdata=dSARqynznihVAD83wrvgFBkrgZyLTJCJCf8X8InuiW0%3D&reserved=0>

  _____

The first infant case of COVID-19 acquired from a secondary transmission in Vietnam<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3D95f8eb6b20%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652206008797&sdata=555X3YMyrTaeJp%2FDoPCtOASHqk23XWot%2BKLaPoEqfP4%3D&reserved=0>

  _____

[Articles] Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3Db00628c8d7%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652206018798&sdata=EsaZW5kL%2B38%2BVeyR7WxW9%2B8A0a0IMjrsqFxRHZ562%2F4%3D&reserved=0>

  _____

[Articles] Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3D1c2a5b146c%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652206018798&sdata=TXrHLlDcNVLlLFz6Bpz2ixmRMKgA9y1%2FRBHcr4tpfNE%3D&reserved=0>

  _____

SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standard for discharge.<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3Dbb87a1ff58%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652206028788&sdata=1oHkUIgtaaEeYzIDj6SzjyEfSKnODaJy1fEKhDOBe0Q%3D&reserved=0>

  _____

Global epidemiology of coronavirus disease 2019: disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status.<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3Da10c2570c5%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652206028788&sdata=FPxRkk%2FlUi%2Fooh0XqSAO0DUdv0G7HmCegkTmUpb2Muo%3D&reserved=0>

  _____

Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children.<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3D82ee00ef73%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652206038785&sdata=bT0kEDLzT%2Fw%2B87J31M4rRYvGNhgtR0Wzw%2Bhx2p3deLU%3D&reserved=0>

  _____

Asymptomatic SARS-CoV-2 infected patients with persistent negative CT findings.<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3D6bb96dc51f%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652206038785&sdata=UZtYkfzBKUCr9i8a7z3FoXeRz%2FA9pNDQY6cKT6ncHw4%3D&reserved=0>

  _____

Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19).<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3D45a9cb2931%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652206048779&sdata=EgJ9JDX%2BDeBzWXqF1qQH5GAjm4pcSOzl%2BVChvkqBYK4%3D&reserved=0>

  _____

Plus de résultats<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3D26a6606573%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652206048779&sdata=SnPz5nuH0f2Y8kH3igS%2FDA95HWw6wS9TRx3UYAUwvCs%3D&reserved=0>

Thèmes :

Pour consulter l'ensemble des résultats appartenant à une catégorie, cliquer sur un des liens suivants :

*       Épidémiologie<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3Dadef162b65%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652206058773&sdata=1YPLX8mNGkVl%2FUmHW5BfoVqHyxaj%2BvD86LC9xy4%2BiWA%3D&reserved=0>
*       Clinique<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3D0a70630bce%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652206058773&sdata=mJCbupF1W940aaUNcrrr8o9cKATZShRZiIQ7eG4QA44%3D&reserved=0>
*       Mesures PCI<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3D298062e747%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652206068766&sdata=v%2B6i%2BlDIf0cxL3a5oAnI0gsrnMoEXL7ZAHp%2FhAyf5Rc%3D&reserved=0>
*       Mesures PCI communauté<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3D51c0e4c732%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652206068766&sdata=ZeRYAMh2PcceVXuK7XR5qJWoG9ul8wrQO1IpPTQGPZ8%3D&reserved=0>
*       Laboratoire<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3Dd9532c31aa%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652206078764&sdata=iN3TxVlL8JfzwSk%2B0ddQvjefwlcGRxHiQesY6ST6q0o%3D&reserved=0>

À propos :

Ce bulletin de veille scientifique est produit par l'Institut national de santé publique du Québec. Les articles diffusés ont été sélectionnés en fonction de leur pertinence. La qualité des articles n'a pas été évaluée.
Pour les recommandations en vigueur au Québec, se référer au site du MSSS<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3D297578103d%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652206078764&sdata=tvFu0of%2BsPCycXSSvPAbPD%2BtuBKWAnmXma9YISvic2c%3D&reserved=0>.

Vous recevez ce courriel car vous êtes inscrit sur notre liste d'envoi.
INSPQ<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Ftrack%2Fclick%3Fu%3D06a417261be399d117f53f71a%26id%3D244346332b%26e%3D3777a06d51&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652206088755&sdata=jsral1UKR9xHIEU4bwPPT%2BtvcldSbDiVEJBFhRFd%2Fyg%3D&reserved=0>

Notre adresse :
Institut national de santé publique du Québec
190, boulevard Crémazie Est
Montréal (Québec) H2P 1E2

Pour vous désabonner<https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Finspq.us20.list-manage.com%2Funsubscribe%3Fu%3D06a417261be399d117f53f71a%26id%3Db5d9f3a57e%26e%3D3777a06d51%26c%3D3c2bd34e8b&data=02%7C01%7Ccom-civilsecurity.nrbhss%40ssss.gouv.qc.ca%7C7bae825780974ec7484308d7d012f8b0%7C06e1fe285f8b4075bf6cae24be1a7992%7C0%7C0%7C637206652206088755&sdata=ijr91uKoUI1kkhug1KM79H7dImSH87HKKl9t0m6nZMQ%3D&reserved=0>.